PregLem is pleased to announce that, effective November 2007, the European Commission and the European Medicines Agency (EMEA) has granted PregLem incentives reserved for Small and Medium Sized Enterprises (SMEs).
The SME program is an initiative by the EMEA dedicated to addressing the particular needs of SMEs developing medicinal products in Europe. Under the SME status, companies are able to seek administrative and procedural assistance from the SME office at the EMEA. In addition, SME status may accord companies reduced or deferred fees associated with Marketing Authorization Applications, scientific advice, and inspections. PregLem has established a branch office in Massongy, 74140 Haute Savoie, France, to which SME status has been granted.
For all information please contact the company at +41(0)22 884 03 40 or at info@preglem.com |
